Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

An Indian female lab technician holds the test cartridge tested in the study in her right hand.
© LMU/Laura Olbrich, Craig Dalgarno

New tool makes it easier to diagnose tuberculosis in children

Around 240,000 children worldwide die of tuberculosis every year. The disease is among the top ten causes of death in children under the age of five. One of the main reasons for this mortality is that

Whitish Acinetobacter baumannii colonies on a red agar plate
© Harald Seifert

Avoiding the further spread of carbapenem-resistant Acinetobacter baumannii

Researchers from the German Center for Infection Research (DZIF) at the University of Cologne have conducted a study on the carbapenem-resistant bacterium Acinetobacter baumannii. The pathogen was

A photo of the podium - part of the audience can be seen from behind. Joël Denis stands at the lectern, the presentation slides are shown on a large screen.
© vfa/Konrad

How to create incentives for the development of novel antibiotics?

Every year at least 700,000 people die as a result of infection with antibiotic-resistant bacteria—a figure which according to WHO forecasts could rise to ten million people by 2050 without new

The award winner Ralf Bartenschlager stands in the middle of the picture, to his right is Nadja Käding from the DZIF Academy, and to the left of Prof. Bartenschlager is DZIF Chairman Prof. Dirk Busch.
© DZIF/U. Pucknat | info@pucknat.pictures

Virologist Ralf Bartenschlager honoured with the DZIF Prize for Translational Infection Research

The German Center for Infection Research (DZIF) honours the virologist Prof. Dr Dr h. c. Ralf Bartenschlager from the Heidelberg University Hospital. The DZIF Prize for Translational Infection

Portrait of Dr. Janko Sattler. Mr Sattler is wearing a dark suit and tie.
© Michel Buchmann

Research award for DZIF Scientist Janko Sattler

DZIF scientist Dr Janko Sattler, a medical specialist at the Institute for Medical Microbiology, Immunology and Hygiene at the University Hospital Cologne, was awarded the bioMérieux Diagnostics Prize

Incate
© INCATE

Successfully promoting new approaches to antibacterial therapies: INCATE celebrates its two-year anniversary

The INCubator for Antibacterial Therapies in Europe, INCATE, can point to an impressive series of successes on its two-year anniversary. With direct contact to more than 180 start-ups and initiatives

Prof. Marylyn (left) receiving the Cross of the Order of Merit of the Federal Republic of Germany in Hamburg. Science Senator Katharina Fegebank is standing to her right.
© Hamburger Behörde für Wissenschaft, Forschung, Gleichstellung und Bezirke (BWFGB)

Professor Marylyn Addo receives the Cross of the Order of Merit of the Federal Republic of Germany

Prof. Marylyn Addo was awarded the Cross of the Order of Merit of the Federal Republic of Germany on August 25, 2023. She received the honour for her outstanding medical and scientific achievements in

The photo shows a group of four researchers (three women and one man) in white lab coats in a laboratory.
© Uni Bonn/Gregor Hübl

Researchers decode new antibiotic agent

More and more bacterial pathogens are developing resistance. There is an increasing risk that current drugs will no longer be effective against infectious diseases. Scientists around the world are

Prof. Rolf Müller (left in the picture) during the award ceremony of the Charles Thom Award in Minneapolis.
© SIMB, 2023 SIMB Annual Meeting

Charles Thom Award 2023 for Rolf Müller

Prof. Rolf Müller, the Founding and Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, has

Schematic representation of a liver (in brown-orange) surrounded by round virus particles and blood cells (in white-gray).
© bluebay 2024/AdobeStock

A promising investigational therapeutic monoclonal antibody to treat chronic hepatitis B and D infections

Affecting hundreds of millions of people, chronic hepatitis B is a widespread global health problem for which there is as yet no cure. In a preclinical study involving the German Center for Infection